Schedule of Warrant and Stock Option Grants with Time-Based Vesting |
The number of shares of the
Company’s common stock that are issuable pursuant to warrant and stock option grants with time-based vesting as of and for the year
ended December 31, 2024 are:
|
|
Warrant Grants |
|
|
Stock Option Grants |
|
|
Restricted
Stock Units |
|
|
|
Number of
shares
subject to
warrants |
|
|
Weighted-
average
exercise price per
share |
|
|
Number of
shares
subject to
options |
|
|
Weighted-
average
exercise price per
share |
|
|
Number of
shares
subject to
restricted
stock units |
|
Balance at December 31, 2023 |
|
|
11,394 |
|
|
$ |
58.72 |
|
|
|
3,333 |
|
|
$ |
39.60 |
|
|
|
165,663 |
|
Granted |
|
|
8,916,697 |
|
|
|
0.86 |
|
|
|
- |
|
|
|
- |
|
|
|
151,290 |
|
Exercised |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(152,957 |
) |
Cancelled/Expired |
|
|
(2,293 |
) |
|
|
53.64 |
|
|
|
(3,333 |
) |
|
|
39.60 |
|
|
|
(41,722 |
) |
Balance at December 31, 2024 |
|
|
8,925,798 |
|
|
$ |
0.92 |
|
|
|
- |
|
|
$ |
- |
|
|
|
122,274 |
|
Exercisable at December 31, 2024 |
|
|
8,925,798 |
|
|
$ |
0.92 |
|
|
|
- |
|
|
$ |
- |
|
|
|
122,274 |
|
The number of shares of the
Company’s common stock that are issuable pursuant to warrant and stock option grants with time-based vesting as of and for the year
ended December 31, 2023 are:
|
|
Warrant Grants |
|
|
Stock Option Grants |
|
|
Restricted
Stock Units |
|
|
|
Number of
shares
subject to
warrants |
|
|
Weighted-
average
exercise price per
share |
|
|
Number of
shares
subject to
options |
|
|
Weighted- average
exercise
price per
share |
|
|
Number of
shares
subject to
restricted
stock units |
|
Balance at December 31, 2022 |
|
|
104,515 |
|
|
$ |
20.25 |
|
|
|
7,891 |
|
|
$ |
48.75 |
|
|
|
160,653 |
|
Granted |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
95,624 |
|
Exercised |
|
|
(54,872 |
) |
|
|
9.75 |
|
|
|
- |
|
|
|
- |
|
|
|
(86,003 |
) |
Cancelled/Expired |
|
|
(38,249 |
) |
|
|
23.73 |
|
|
|
(4,558 |
) |
|
|
55.43 |
|
|
|
(4,611 |
) |
Balance at December 31, 2023 |
|
|
11,394 |
|
|
$ |
58.72 |
|
|
|
3,333 |
|
|
$ |
39.60 |
|
|
|
165,663 |
|
Exercisable at December 31, 2023 |
|
|
11,394 |
|
|
$ |
58.72 |
|
|
|
3,333 |
|
|
$ |
39.60 |
|
|
|
165,663 |
|
|
Schedule of Outstanding Warrants |
|
|
For the years ended |
|
|
|
December 31, |
|
|
|
2024 |
|
|
2023 |
|
Stock-based compensation expense |
|
$ |
- |
|
|
$ |
361,363 |
|
Stock-based compensation expense
categorized by the equity components for the years ended December 31, 2024 and 2023 is as follows:
|
|
For the years ended |
|
|
|
December 31, |
|
|
|
2024 |
|
|
2023 |
|
Common stock |
|
$ |
- |
|
|
$ |
361,363 |
|
Total |
|
$ |
- |
|
|
$ |
361,363 |
|
|
Schedule of Company’s Outstanding Warrants and Options |
The Company’s outstanding
warrants at December 31, 2024 are as follows:
Warrants Outstanding |
| Warrants Exercisable |
Exercise Price Range |
| Number Outstanding |
|
| Weighted Average Remaining Contractual Life (in years) |
|
| Weighted Average Exercise Price |
|
| Number Exercisable |
| Weighted Average Exercise Price |
|
| Intrinsic Value |
|
$0.86– $60.00 |
| |
8,925,798 |
|
| |
4.55 |
|
| $ |
0.92 |
|
| 8,925,798 |
| $ |
0.95 |
|
| $ |
7,400,859 |
|
|